Esben Selmer Buhl

1.2k total citations
24 papers, 1.0k citations indexed

About

Esben Selmer Buhl is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Esben Selmer Buhl has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Esben Selmer Buhl's work include Metabolism, Diabetes, and Cancer (9 papers), Diabetes Management and Research (7 papers) and Diabetes Treatment and Management (7 papers). Esben Selmer Buhl is often cited by papers focused on Metabolism, Diabetes, and Cancer (9 papers), Diabetes Management and Research (7 papers) and Diabetes Treatment and Management (7 papers). Esben Selmer Buhl collaborates with scholars based in Denmark, Norway and United States. Esben Selmer Buhl's co-authors include Sten Lund, Niels Jessen, Ole Schmitz, Rasmus Pold, Steen B. Pedersen, Oluf Pedersen, Allan Flyvbjerg, Lasse S. Jensen, Geoffrey D. Holman and Ole Schmitz and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Esben Selmer Buhl

23 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Esben Selmer Buhl Denmark	12	622	410	314	290	156	24	1.0k
Rasmus Rabøl Denmark	18	625 1.0×	644 1.6×	323 1.0×	652 2.2×	259 1.7×	26	1.5k
Jean‐Paul Kovalik Singapore	22	553 0.9×	530 1.3×	206 0.7×	209 0.7×	209 1.3×	67	1.3k
Christine A. Doucette Canada	16	330 0.5×	280 0.7×	290 0.9×	142 0.5×	130 0.8×	24	918
Junji Kawashima Japan	19	396 0.6×	355 0.9×	422 1.3×	413 1.4×	199 1.3×	52	1.2k
Anna D’Amore Italy	11	186 0.3×	356 0.9×	188 0.6×	213 0.7×	101 0.6×	29	870
Melissa A. Linden United States	20	387 0.6×	616 1.5×	121 0.4×	205 0.7×	346 2.2×	43	1.1k
Miikka‐Juhani Honka Finland	15	229 0.4×	387 0.9×	213 0.7×	335 1.2×	286 1.8×	39	927
Edoardo Dalla Nora Italy	17	553 0.9×	512 1.2×	157 0.5×	127 0.4×	193 1.2×	37	1.2k
Annette M. Chang United States	16	388 0.6×	300 0.7×	460 1.5×	811 2.8×	184 1.2×	30	1.4k

Countries citing papers authored by Esben Selmer Buhl

Since Specialization

Citations

This map shows the geographic impact of Esben Selmer Buhl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esben Selmer Buhl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esben Selmer Buhl more than expected).

Fields of papers citing papers by Esben Selmer Buhl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esben Selmer Buhl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esben Selmer Buhl. The network helps show where Esben Selmer Buhl may publish in the future.

Co-authorship network of co-authors of Esben Selmer Buhl

This figure shows the co-authorship network connecting the top 25 collaborators of Esben Selmer Buhl. A scholar is included among the top collaborators of Esben Selmer Buhl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esben Selmer Buhl. Esben Selmer Buhl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strandberg, Ragnhild B., Roy M. Nilsen, Frans Pouwer, et al.. (2025). Pharmacologically treated depression, anxiety, and insomnia in individuals with type 2 diabetes: The role of diabetes duration, age, and age at diabetes onset. A Norwegian population-based registry study from the OMIT cohort. Journal of Psychosomatic Research. 190. 112057–112057.

Igland, Jannicke, Rachel Forster, Anne Karen Jenum, et al.. (2024). How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway. BMJ Open. 14(3). e077027–e077027. 2 indexed citations

Jenum, Anne Karen, Lars J. Kirkebøen, Tore Julsrud Berg, et al.. (2024). High prevalence of retinopathy in young-onset type 2 diabetes and possible sex differences: insights from Norwegian general practice. BMJ Open Diabetes Research & Care. 12(1). e003624–e003624. 2 indexed citations

Mdala, Ibrahimu, Tore Julsrud Berg, John G. Cooper, et al.. (2023). Insulin initiation in patients with type 2 diabetes is often delayed, but access to a diabetes nurse may help—insights from Norwegian general practice. Scandinavian Journal of Primary Health Care. 42(1). 132–143. 1 indexed citations

Forster, Rachel, Ragnhild B. Strandberg, Tore Julsrud Berg, et al.. (2022). Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) – a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway. BMJ Open. 12(5). e054840–e054840. 5 indexed citations

Strandberg, Ragnhild B., Frans Pouwer, Jannicke Igland, et al.. (2022). Lower education and immigrant background are associated with lower participation in a diabetes education program – Insights from adult patients in the Outcomes & Multi-morbidity In Type 2 diabetes cohort (OMIT). Patient Education and Counseling. 107. 107577–107577. 1 indexed citations

Claudi, Tor, Knut Tore Lappegård, Anne Karen Jenum, et al.. (2022). Level of education is associated with coronary heart disease and chronic kidney disease in individuals with type 2 diabetes: a population-based study. BMJ Open Diabetes Research & Care. 10(5). e002867–e002867. 7 indexed citations

Svensson, Elisabeth, Lisbeth M. Baggesen, Søren Paaske Johnsen, et al.. (2017). Early Glycemic Control and Magnitude of HbA1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators. Diabetes Care. 40(6). 800–807. 56 indexed citations

Stødkilde‐Jørgensen, Hans, Poul Videbech, Allan Vaag, et al.. (2017). Escitalopram Ameliorates Hypercortisolemia and Insulin Resistance in Low Birth Weight Men With Limbic Brain Alterations. The Journal of Clinical Endocrinology & Metabolism. 103(1). 115–124. 10 indexed citations

10.

Thomsen, Reimar W., Lisbeth M. Baggesen, Mette Søgaard, et al.. (2015). Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes. Diabetologia. 58(10). 2247–2253. 25 indexed citations

11.

Thomsen, Reimar W., Lisbeth M. Baggesen, Elisabeth Svensson, et al.. (2015). Early glycaemic control among patients with type 2 diabetes and initial glucose‐lowering treatment: a 13‐year population‐based cohort study. Diabetes Obesity and Metabolism. 17(8). 771–780. 34 indexed citations

12.

Buhl, Esben Selmer, Thomas Korgaard Jensen, Niels Jessen, et al.. (2010). Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats. American Journal of Physiology-Endocrinology and Metabolism. 298(5). E920–E929. 36 indexed citations

13.

Kristiansen, Steen Buus, Bo Løfgren, Jan M. Nielsen, et al.. (2010). Comparison of two sulfonylureas with high and low myocardial KATP channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes. Diabetologia. 54(2). 451–458. 23 indexed citations

14.

Jessen, Niels, Esben Selmer Buhl, Rasmus Pold, O. Schmitz, & Sten Lund. (2008). A Novel Insulin Sensitizer (S15511) Enhances Insulin-stimulated Glucose Uptake in Rat Skeletal Muscles. Hormone and Metabolic Research. 40(4). 269–275. 6 indexed citations

15.

Buhl, Esben Selmer, Susanne Neschen, Shin Yonemitsu, et al.. (2007). Increased hypothalamic-pituitary-adrenal axis activity and hepatic insulin resistance in low-birth-weight rats. American Journal of Physiology-Endocrinology and Metabolism. 293(5). E1451–E1458. 27 indexed citations

16.

Pold, Rasmus, Lasse S. Jensen, Niels Jessen, et al.. (2005). Long-Term AICAR Administration and Exercise Prevents Diabetes in ZDF Rats. Diabetes. 54(4). 928–934. 178 indexed citations

17.

Jessen, Niels, Rasmus Pold, Esben Selmer Buhl, et al.. (2003). Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. Journal of Applied Physiology. 94(4). 1373–1379. 141 indexed citations

18.

Buhl, Esben Selmer, Niels Jessen, Rasmus Pold, et al.. (2002). Long-Term AICAR Administration Reduces Metabolic Disturbances and Lowers Blood Pressure in Rats Displaying Features of the Insulin Resistance Syndrome. Diabetes. 51(7). 2199–2206. 203 indexed citations

19.

Pedersen, Steen B., Sten Lund, Esben Selmer Buhl, & Bjørn Richelsen. (2001). Insulin and Contraction Directly Stimulate UCP2 and UCP3 mRNA Expression in Rat Skeletal Muscle in Vitro. Biochemical and Biophysical Research Communications. 283(1). 19–25. 55 indexed citations

20.

Buhl, Esben Selmer, Niels Jessen, Ole Schmitz, et al.. (2001). Chronic Treatment With 5-Aminoimidazole-4-Carboxamide-1- -D-Ribofuranoside Increases Insulin-Stimulated Glucose Uptake and GLUT4 Translocation in Rat Skeletal Muscles in a Fiber Type--Specific Manner. Diabetes. 50(1). 12–17. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact